Medtronic completes PMA filing for Talent

Interventional technology firm Medtronic has filed the final module of its premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for its Talent abdominal stent graft system.

Talent is designed to treat dangerous bulges in the aorta, according to the Minneapolis-based company.

Related Reading

FDA clears Medtronic's biliary stent system, November 15, 2007

Medtronic nets CE Mark, October 23, 2007

Medtronic's Endeavor moves closer to clearance, October 11, 2007

Medtronic launches CareLink in Europe, August 30, 2007

Medtronic names new CEO, COO, August 24, 2007

Copyright © 2007 AuntMinnie.com

Page 1 of 181
Next Page